Memorial Sloan Kettering Cancer Center
2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New SoC as First-line Therapy in Patients With MSI-H mCRC?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Louise Connell
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Louise Connell
Login to view comments.
Click here to Login